文献速递消化道肿瘤放疗

直肠癌术前放化疗后环周切缘对复发与生存的连续影响:多中心回顾性分析

Continuous Effect of Radial Resection Margin on Recurrence and Survival in Rectal Cancer Patients Who Receive Preoperative Chemoradiation and Curative Surgery: A Multicenter Retrospective Analysis.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2017-03-14

该多中心回顾性分析纳入1476例cT3-4N0-2M0直肠癌患者,均接受50.4 Gy/28次术前放化疗后行全直肠系膜切除术。结果显示环周切缘(CRM)≤1 mm者5年无复发生存率最低(46.2%),CRM 1.1–5 mm者居中(68.6%),CRM>5 mm者最高(77.5%,P<.001);远端切缘≤5 mm与>5 mm在局部复发和远处转移上无显著差异。

要点

  • CRM≤1 mm为高危组,5年RFS仅46.2%,局部复发和远处转移均显著升高。
  • CRM 1.1–5 mm为中等风险组,远处转移显著增加但局部复发无显著差异。
  • 远端切缘≤5 mm与>5 mm在局部复发(P=.310)和远处转移(P=.926)上无显著差异。

核心结论

  • CRM≤1 mm的直肠癌患者为高危组,无复发生存率最低。
  • CRM 1.1–5 mm患者可能为中等风险组,远处复发中度增加。
  • 新辅助放化疗及全直肠系膜切除后,远端切缘与无复发生存无显著关联。

研究设计与样本

  • 多中心回顾性分析,纳入1476例cT3-4N0-2M0直肠癌患者。
  • 所有患者接受50.4 Gy/28次放疗,同步5-氟尿嘧啶或卡培他滨化疗。
  • 放疗后4–8周行全直肠系膜切除术。

主要发现

  • 5年无复发生存率在CRM≤1 mm、1.1–5 mm、>5 mm三组间差异显著(46.2% vs 68.6% vs 77.5%,P<.001)。
  • CRM≤1 mm组5年局部区域复发累积发生率显著高于其他两组(P<.001)。
  • CRM≤1 mm组5年远处转移累积发生率显著高于其他两组(P<.001)。
  • CRM 1.1–5 mm组远处转移累积发生率显著高于CRM>5 mm组(P<.001),但局部区域复发无显著差异(P=.192)。
  • 远端切缘≤5 mm与>5 mm在局部区域复发(P=.310)和远处转移(P=.926)累积发生率上无显著差异。

关键数值与推荐

  • CRM分组标准:≤1 mm、1.1–5 mm、>5 mm。
  • 远端切缘分组标准:≤5 mm与>5 mm。
  • 放疗剂量50.4 Gy/28次,同步5-氟尿嘧啶或卡培他滨。
  • 手术时机为放疗后4–8周。

临床怎么用

  • 术后病理报告应明确CRM测量值,按≤1 mm、1.1–5 mm、>5 mm分层评估风险。
  • CRM≤1 mm患者属高危,需重点考虑辅助治疗强化和密切随访。
  • CRM 1.1–5 mm患者应关注远处转移风险,可能需要相应监测策略。
  • 远端切缘≤5 mm不作为独立的不良预后指标用于分层。

局限性

  • 本文为回顾性分析,可能存在选择偏倚和混杂因素。
  • 摘要未报告随访时长、具体辅助治疗细节及多因素校正结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To elucidate the proper length and prognostic value of resection margins in rectal cancer patients who received preoperative chemoradiotherapy (CRT) followed by curative total mesorectal excision (TME). METHODS AND MATERIALS: A total of 1476 rectal cancer patients staging cT3-4N0-2M0 were analyzed. All patients received radiation dose of 50.4 Gy in 28 fractions with concurrent 5-fluorouracil or capecitabine. Total mesorectal excision was performed 4 to 8 weeks after radiation therapy. RESULTS: The recurrence-free survival (RFS) at 5 years showed a significant difference between 3 groups: patients with circumferential resection margin (CRM) ≤1 mm, CRM 1.1 to 5 mm, and CRM >5 mm (46.2% vs 68.6% vs 77.5%, P<.001). Patients with CRM ≤1 mm showed a significantly higher cumulative incidence of locoregional recurrence (P<.001) and distant metastasis (P<.001) at 5 years compared with the other 2 groups. Patients with CRM 1.1 to 5 mm showed a significantly higher cumulative incidence of distant metastasis (P<.001), but not locoregional recurrence (P=.192), compared with those with CRM >5 mm. Distal resection margin (≤5 vs >5 mm) did not show any significant difference in cumulative incidence of locoregional recurrence (P=.310) and distant metastasis (P=.926). CONCLUSION: Rectal cancer patients with CRM ≤1 mm are a high-risk group, with the lowest RFS. Patients with CRM 1.1 to 5 mm may be at intermediate risk, with moderately increased distant recurrence. Distal resection margin was not significantly associated with RFS in rectal cancer after neoadjuvant CRT and total mesorectal excision.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Sung S, Kim SH, Lee JH, et al. Continuous Effect of Radial Resection Margin on Recurrence and Survival in Rectal Cancer Patients Who Receive Preoperative Chemoradiation and Curative Surgery: A Multicenter Retrospective Analysis. Int J Radiat Oncol Biol Phys. 2017. PMID: 28581407. doi:10.1016/j.ijrobp.2017.03.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。